BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3040780)

  • 21. Identification of a collagen potentiated neurite promoting factor isolated from C6 glioma cells.
    Coyle DE
    J Neurosci Res; 1993 Jul; 35(4):390-401. PubMed ID: 8360947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
    Eaton DL; Scott RW; Baker JB
    J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin.
    Scott RW; Eaton DL; Duran N; Baker JB
    J Biol Chem; 1983 Apr; 258(7):4397-403. PubMed ID: 6339496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines.
    Lahiri DK; Lewis S; Farlow MR
    J Neurosci Res; 1994 Apr; 37(6):777-87. PubMed ID: 8046778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator and serine protease inhibitor-E2 (protease nexin-1) expression by bovine granulosa cells in vitro.
    Cao M; Sahmi M; Lussier JG; Price CA
    Biol Reprod; 2004 Sep; 71(3):887-93. PubMed ID: 15128599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of serine proteases with cultured fibroblasts.
    Cunningham DD; Van Nostrand WE; Farrell DH; Campbell CH
    J Cell Biochem; 1986; 32(4):281-91. PubMed ID: 3543029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors.
    Mbebi C; Hantaï D; Jandrot-Perrus M; Doyennette MA; Verdière-Sahuqué M
    J Cell Physiol; 1999 Jun; 179(3):305-14. PubMed ID: 10228949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease nexin 1 is expressed in the human placenta.
    White EA; Baker JB; McGrogan M; Kitos PA
    Thromb Haemost; 1993 Feb; 69(2):119-23. PubMed ID: 8456423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of protease nexin-1 target protease specificity by collagen type IV.
    Donovan FM; Vaughan PJ; Cunningham DD
    J Biol Chem; 1994 Jun; 269(25):17199-205. PubMed ID: 8006028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease nexin I, thrombin- and urokinase-inhibiting serpin, concentrated in normal human cerebrospinal fluid.
    Festoff BW; Rao JS; Chen M
    Neurology; 1992 Jul; 42(7):1361-6. PubMed ID: 1620346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells.
    Hedberg KK; Stauff C; Høyer-Hansen G; Rønne E; Griffith OH
    Exp Cell Res; 2000 May; 257(1):67-81. PubMed ID: 10854055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin, and urokinase.
    Stone SR; Nick H; Hofsteenge J; Monard D
    Arch Biochem Biophys; 1987 Jan; 252(1):237-44. PubMed ID: 3813534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification of a form of protease nexin 1 that binds heparin with a low affinity.
    Van Nostrand WE; Wagner SL; Cunningham DD
    Biochemistry; 1988 Mar; 27(6):2176-81. PubMed ID: 3378053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque.
    Mansilla S; Boulaftali Y; Venisse L; Arocas V; Meilhac O; Michel JB; Jandrot-Perrus M; Bouton MC
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1844-50. PubMed ID: 18617644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of protease nexin-thrombin complexes on the platelet surface.
    Gronke RS; Curry TK; Baker JB
    J Cell Biochem; 1986; 32(3):201-6. PubMed ID: 3782314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.
    Low DA; Baker JB; Koonce WC; Cunningham DD
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2340-4. PubMed ID: 7017731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of protease nexin-1 and angiotensin II receptor subtype 1 expression: inverse relationship in experimental models of nerve injury.
    Bleuel A; Monard D
    J Neurosci Res; 1995 Nov; 42(4):562-70. PubMed ID: 8568942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.
    Wagner SL; Geddes JW; Cotman CW; Lau AL; Gurwitz D; Isackson PJ; Cunningham DD
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8284-8. PubMed ID: 2813392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biosynthesis of protease nexin-I.
    Howard EW; Knauer DJ
    J Biol Chem; 1986 Oct; 261(30):14184-90. PubMed ID: 3771529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.